These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10389607)

  • 21. The economic burden of affective disorders.
    Rice DP; Miller LS
    Br J Psychiatry Suppl; 1995 Apr; (27):34-42. PubMed ID: 7794592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost of care of schizophrenia: a study of Indian out-patient attenders.
    Grover S; Avasthi A; Chakrabarti S; Bhansali A; Kulhara P
    Acta Psychiatr Scand; 2005 Jul; 112(1):54-63. PubMed ID: 15952946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The current economic burden of illness of osteoporosis in Canada.
    Hopkins RB; Burke N; Von Keyserlingk C; Leslie WD; Morin SN; Adachi JD; Papaioannou A; Bessette L; Brown JP; Pericleous L; Tarride J
    Osteoporos Int; 2016 Oct; 27(10):3023-32. PubMed ID: 27166680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The economic burden of major adult visual disorders in the United States.
    Rein DB; Zhang P; Wirth KE; Lee PP; Hoerger TJ; McCall N; Klein R; Tielsch JM; Vijan S; Saaddine J
    Arch Ophthalmol; 2006 Dec; 124(12):1754-60. PubMed ID: 17159036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The economic burden of physical inactivity in Canada.
    Katzmarzyk PT; Gledhill N; Shephard RJ
    CMAJ; 2000 Nov; 163(11):1435-40. PubMed ID: 11192648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The costs of schizophrenia in Spain.
    Oliva-Moreno J; López-Bastida J; Osuna-Guerrero R; Montejo-González AL; Duque-González B
    Eur J Health Econ; 2006 Sep; 7(3):182-88. PubMed ID: 16850333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Smoking-attributable productivity loss in Germany--a partial sickness cost study based on the human capital potential method].
    Wegner C; Gutsch A; Hessel F; Wasem J
    Gesundheitswesen; 2004 Jul; 66(7):423-32. PubMed ID: 15314734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The economic burden of coronary heart disease in the UK.
    Liu JL; Maniadakis N; Gray A; Rayner M
    Heart; 2002 Dec; 88(6):597-603. PubMed ID: 12433888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The analysis of the cost structures of the treatment of schizophrenia by means of standardized assessment instruments].
    Kilian R; Roick C; Matschinger H; Bernert S; Mory C; Angermeyer MC
    Psychiatr Prax; 2001 Oct; 28 Suppl 2():S102-8. PubMed ID: 11605132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cost of schizophrenia.
    Wasylenki DA
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S65-9. PubMed ID: 7874667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost of depression in Europe.
    Sobocki P; Jönsson B; Angst J; Rehnberg C
    J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Smoking-attributable morbidity: acute care hospital diagnoses and days of treatment in Canada, 2002.
    Baliunas D; Patra J; Rehm J; Popova S; Taylor B
    BMC Public Health; 2007 Sep; 7():247. PubMed ID: 17877815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outpatient antipsychotic treatment and inpatient costs of schizophrenia.
    Marcus SC; Olfson M
    Schizophr Bull; 2008 Jan; 34(1):173-80. PubMed ID: 17578893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic burden of low cardiorespiratory fitness in Canada.
    Chaput JP; Janssen I; Sampasa-Kanyinga H; Tomkinson GR; Lang JJ
    Prev Med; 2023 Mar; 168():107424. PubMed ID: 36682702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alcohol-attributable morbidity and resulting health care costs in Canada in 2002: recommendations for policy and prevention.
    Taylor B; Rehm J; Patra J; Popova S; Baliunas D
    J Stud Alcohol Drugs; 2007 Jan; 68(1):36-47. PubMed ID: 17149516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An analysis of the costs of treating schizophrenia in Spain: a hierarchical Bayesian approach.
    Vázquez-Polo FJ; Negrín M; Cabasés JM; Sánchez E; Haro JM; Salvador-Carulla L
    J Ment Health Policy Econ; 2005 Sep; 8(3):153-65. PubMed ID: 16278503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic burden of insomnia symptoms in Canada.
    Chaput JP; Janssen I; Sampasa-Kanyinga H; Carney CE; Dang-Vu TT; Davidson JR; Robillard R; Morin CM
    Sleep Health; 2023 Apr; 9(2):185-189. PubMed ID: 36319579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cost-of-illness trend of schizophrenia in South Korea from 2006 to 2016.
    Jo M; Kim HJ; Rim SJ; Lee MG; Kim CE; Park S
    PLoS One; 2020; 15(7):e0235736. PubMed ID: 32673350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The economic burden of depression in 1990.
    Greenberg PE; Stiglin LE; Finkelstein SN; Berndt ER
    J Clin Psychiatry; 1993 Nov; 54(11):405-18. PubMed ID: 8270583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Economic Burden of Fetal Alcohol Spectrum Disorder in Canada in 2013.
    Popova S; Lange S; Burd L; Rehm J
    Alcohol Alcohol; 2016 May; 51(3):367-75. PubMed ID: 26493100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.